US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Terminated

Ethanol 70% 0.5ml Syringe

Reason Lack of sterility assurance

Sentara Infusion Services D-0292-2023
Class II · Moderate risk Terminated

Ertapenem

Reason Lack of sterility assurance

Sentara Infusion Services D-0291-2023
Class II · Moderate risk Terminated

Dobutamine

Reason Lack of sterility assurance

Sentara Infusion Services D-0290-2023
Class II · Moderate risk Terminated

Dextrose 10% 720ML

Reason Lack of sterility assurance

Sentara Infusion Services D-0288-2023
Class II · Moderate risk Terminated

Daptomycin

Reason Lack of sterility assurance

Sentara Infusion Services D-0287-2023
Class II · Moderate risk Terminated

Daptomycin

Reason Lack of sterility assurance

Sentara Infusion Services D-0286-2023
Class II · Moderate risk Terminated

D5 Ns 2300ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0284-2023
Class II · Moderate risk Terminated

Ceftriaxone

Reason Lack of sterility assurance

Sentara Infusion Services D-0283-2023
Class II · Moderate risk Terminated

Ceftriaxone

Reason Lack of sterility assurance

Sentara Infusion Services D-0282-2023
Class II · Moderate risk Terminated

Cefoxitin

Reason Lack of sterility assurance

Sentara Infusion Services D-0281-2023
Class II · Moderate risk Terminated

Cefepime

Reason Lack of sterility assurance

Sentara Infusion Services D-0280-2023
Class II · Moderate risk Terminated

Cefazolin

Reason Lack of sterility assurance

Sentara Infusion Services D-0278-2023
Class II · Moderate risk Terminated

Caspofungin 50mg in Ns 100ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0277-2023
Class II · Moderate risk Terminated

Ampicillin 8gm in Ns 400ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0275-2023
Class II · Moderate risk Terminated

Ampicillin 12gm in Ns 600m

Reason Lack of sterility assurance

Sentara Infusion Services D-0274-2023
Class II · Moderate risk Terminated

Amikacin 450MG IN NS 45ML

Reason Lack of sterility assurance

Sentara Infusion Services D-0273-2023
Class II · Moderate risk Terminated

0.9% Sodium Chloride

Reason Lack of sterility assurance

Sentara Infusion Services D-0272-2023
Class III · Low risk Terminated

Prochlorperazine Maleate Tablets

Reason Subpotent Drug: Out of specification for assay at the 18-month stability timepoint.

Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-113-06 D-0096-2023
Class I · High risk Terminated

Easy Care First Aid 10 Person 2009 ANSI

Reason Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

GFA Production Xiamen Co. Ltd. D-0253-2023
Class I · High risk Terminated

CVS First Aid Home

Reason Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

GFA Production Xiamen Co. Ltd. D-0252-2023
Class I · High risk Terminated

Easy Care First Aid 25 Person 2009 ANSI

Reason Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

GFA Production Xiamen Co. Ltd. D-0251-2023